{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T01:58:34Z","timestamp":1761789514055,"version":"3.37.3"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2018,8,17]],"date-time":"2018-08-17T00:00:00Z","timestamp":1534464000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100014588","name":"Sanofi Pasteur","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100014588","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s10096-018-3348-x","type":"journal-article","created":{"date-parts":[[2018,8,17]],"date-time":"2018-08-17T06:00:40Z","timestamp":1534485640000},"page":"2123-2130","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Outcomes of Clostridium difficile-suspected diarrhea in a French university hospital"],"prefix":"10.1007","volume":"37","author":[{"name":"CDI01 Study Group","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nagham","family":"Khanafer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Vanhems","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Barbut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Eckert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Perraud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Vandenesch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Luxemburger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clarisse","family":"Demont","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,8,17]]},"reference":[{"issue":"4","key":"3348_CR1","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jhin.2014.05.002","volume":"87","author":"M Martin","year":"2014","unstructured":"Martin M, Zingg W, Knoll E, Wilson C, Dettenkofer M, Group PS (2014) National European guidelines for the prevention of Clostridium difficile infection: a systematic qualitative review. J Hosp Infect 87(4):212\u2013219. https:\/\/doi.org\/10.1016\/j.jhin.2014.05.002","journal-title":"J Hosp Infect"},{"key":"3348_CR2","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1038\/ajg.2014.167","volume":"109","author":"P Feuerstadt","year":"2014","unstructured":"Feuerstadt P, Das R, Brandt LJ (2014) The evolution of Urban C. difficile infection (CDI): CDI in 2009\u20132011 is less severe and has better outcomes than CDI in 2006\u20132008. Am J Gastroenterol 109:1265\u20131276","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"3348_CR3","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/j.1469-0691.2012.03910.x","volume":"19","author":"J Kim","year":"2013","unstructured":"Kim J, Kang JO, Kim H, Seo MR, Choi TY, Pai H, Kuijper EJ, Sanders I, Fawley W (2013) Epidemiology of Clostridium difficile infections in a tertiary-care hospital in Korea. Clin Microbiol Infect 19(6):521\u2013527","journal-title":"Clin Microbiol Infect"},{"issue":"10","key":"3348_CR4","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1086\/522654","volume":"45","author":"CA Muto","year":"2007","unstructured":"Muto CA, Blank MK, Marsh JW, Vergis EN, O\u2019Leary MM, Shutt KA, Pasculle AW, Pokrywka M, Garcia JG, Posey K, Roberts TL, Potoski BA, Blank GE, Simmons RL, Veldkamp P, Harrison LH, Paterson DL (2007) Control of an outbreak of infection with the hypervirulent Clostridium difficile BI strain in a university hospital using a comprehensive \u201cbundle\u201d approach. Clin Infect Dis 45(10):1266\u20131273. https:\/\/doi.org\/10.1086\/522654","journal-title":"Clin Infect Dis"},{"issue":"1","key":"3348_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MOG.0b013e32834bc9a9","volume":"28","author":"A Lo Vecchio","year":"2011","unstructured":"Lo Vecchio A, Zacur GM (2011) Clostridium difficile infection: an update on epidemiology, risk factors, and therapeutic options. Curr Opin Gastroenterol 28(1):1\u20139","journal-title":"Curr Opin Gastroenterol"},{"issue":"4","key":"3348_CR6","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.jhin.2008.01.033","volume":"68","author":"J Bishara","year":"2008","unstructured":"Bishara J, Peled N, Pitlik S, Samra Z (2008) Mortality of patients with antibiotic-associated diarrhoea: the impact of Clostridium difficile. J Hosp Infect 68(4):308\u2013314. https:\/\/doi.org\/10.1016\/j.jhin.2008.01.033","journal-title":"J Hosp Infect"},{"issue":"2","key":"3348_CR7","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.medmal.2013.01.004","volume":"43","author":"C Eckert","year":"2013","unstructured":"Eckert C, Coignard B, Hebert M, Tarnaud C, Tessier C, Lemire A, Burghoffer B, Noel D, Barbut F, Group IC-RW (2013) Clinical and microbiological features of Clostridium difficile infections in France: the ICD-RAISIN 2009 national survey. Med Mal Infect 43(2):67\u201374. https:\/\/doi.org\/10.1016\/j.medmal.2013.01.004","journal-title":"Med Mal Infect"},{"issue":"23","key":"3348_CR8","doi-asserted-by":"publisher","first-page":"e3874","DOI":"10.1097\/MD.0000000000003874","volume":"95","author":"N Khanafer","year":"2016","unstructured":"Khanafer N, Oltra L, Hulin M, Dauwalder O, Vandenesch F, Vanhems P (2016) Clostridium difficile infection in a French university hospital: eight years of prospective surveillance study. Medicine 95(23):e3874. https:\/\/doi.org\/10.1097\/MD.0000000000003874","journal-title":"Medicine"},{"issue":"7","key":"3348_CR9","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1128\/JCM.38.7.2484-2487.2000","volume":"38","author":"P Bidet","year":"2000","unstructured":"Bidet P, Lalande V, Salauze B, Burghoffer B, Avesani V, Delmee M, Rossier A, Barbut F, Petit JC (2000) Comparison of PCR-ribotyping, arbitrarily primed PCR, and pulsed-field gel electrophoresis for typing Clostridium difficile. J Clin Microbiol 38(7):2484\u20132487","journal-title":"J Clin Microbiol"},{"issue":"3","key":"3348_CR10","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1086\/502539","volume":"26","author":"CA Muto","year":"2005","unstructured":"Muto CA, Pokrywka M, Shutt K, Mendelsohn AB, Nouri K, Posey K, Roberts T, Croyle K, Krystofiak S, Patel-Brown S, Pasculle AW, Paterson DL, Saul M, Harrison LH (2005) A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use. Infect Control Hosp Epidemiol 26(3):273\u2013280. https:\/\/doi.org\/10.1086\/502539","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"9","key":"3348_CR11","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1503\/cmaj.050978","volume":"173","author":"J Pepin","year":"2005","unstructured":"Pepin J, Valiquette L, Cossette B (2005) Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec. CMAJ 173(9):1037\u20131042. https:\/\/doi.org\/10.1503\/cmaj.050978","journal-title":"CMAJ"},{"issue":"4","key":"3348_CR12","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1097\/QCO.0b013e32834748e5","volume":"24","author":"F Barbut","year":"2011","unstructured":"Barbut F, Jones G, Eckert C (2011) Epidemiology and control of Clostridium difficile infections in healthcare settings: an update. Curr Opin Infect Dis 24(4):370\u2013376. https:\/\/doi.org\/10.1097\/QCO.0b013e32834748e5","journal-title":"Curr Opin Infect Dis"},{"issue":"5","key":"3348_CR13","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1128\/JCM.03352-12","volume":"51","author":"D Rodriguez-Pardo","year":"2013","unstructured":"Rodriguez-Pardo D, Almirante B, Bartolome RM, Pomar V, Mirelis B, Navarro F, Soriano A, Sorli L, Martinez-Montauti J, Molins MT, Lung M, Vila J, Pahissa A (2013) Epidemiology of Clostridium difficile infection and risk factors for unfavorable clinical outcomes: results of a hospital-based study in Barcelona, Spain. J Clin Microbiol 51(5):1465\u20131473","journal-title":"J Clin Microbiol"},{"key":"3348_CR14","doi-asserted-by":"crossref","unstructured":"Mascart G, Delmee M, Van Broeck J, Cytryn E, Karmali R, Cherifi S (2013) Impact of ribotype 027 on Clostridium difficile infection in a geriatric department. Eur J Clin Microbiol Infect Dis:1435\u20134373","DOI":"10.1007\/s10096-013-1864-2"},{"issue":"10","key":"3348_CR15","doi-asserted-by":"publisher","first-page":"758","DOI":"10.7326\/0003-4819-145-10-200611210-00008","volume":"145","author":"JG Bartlett","year":"2006","unstructured":"Bartlett JG (2006) Narrative review: the new epidemic of Clostridium difficile-associated enteric disease. Ann Intern Med 145(10):758\u2013764","journal-title":"Ann Intern Med"},{"issue":"9","key":"3348_CR16","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1093\/cid\/cit492","volume":"57","author":"C. V. Gould","year":"2013","unstructured":"Gould CV, Edwards JR, Cohen J, Bamberg WM, Clark LA, Farley MM, Johnston H, Nadle J, Winston L, Gerding DN, McDonald LC, Lessa FC, Clostridium difficile Infection Surveillance Investigators, Centers for Disease Control and Prevention (2013) Effect of nucleic acid amplification testing on population-based incidence rates of Clostridium difficile infection. Clin Infect Dis 57 (9):1304\u20131307. https:\/\/doi.org\/10.1093\/cid\/cit492","journal-title":"Clinical Infectious Diseases"},{"issue":"12","key":"3348_CR17","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1093\/cid\/civ749","volume":"61","author":"CN Abou Chakra","year":"2015","unstructured":"Abou Chakra CN, McGeer A, Labbe AC, Simor AE, Gold WL, Muller MP, Powis J, Katz K, Garneau JR, Fortier LC, Pepin J, Cadarette SM, Valiquette L (2015) Factors associated with complications of Clostridium difficile infection in a multicenter prospective cohort. Clin Infect Dis 61(12):1781\u20131788. https:\/\/doi.org\/10.1093\/cid\/civ749","journal-title":"Clin Infect Dis"},{"issue":"3","key":"3348_CR18","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3201\/eid1503.080312","volume":"15","author":"TJ Henrich","year":"2009","unstructured":"Henrich TJ, Krakower D, Bitton A, Yokoe DS (2009) Clinical risk factors for severe Clostridium difficile-associated disease. Emerg Infect Dis 15(3):415\u2013422. https:\/\/doi.org\/10.3201\/eid1503.080312","journal-title":"Emerg Infect Dis"},{"issue":"12","key":"3348_CR19","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1093\/cid\/cir668","volume":"53","author":"RH Morrison","year":"2011","unstructured":"Morrison RH, Hall NS, Said M, Rice T, Groff H, Brodine SK, Slymen D, Lederman ER (2011) Risk factors associated with complications and mortality in patients with Clostridium difficile infection. Clin Infect Dis 53(12):1173\u20131178. https:\/\/doi.org\/10.1093\/cid\/cir668","journal-title":"Clin Infect Dis"},{"issue":"3","key":"3348_CR20","doi-asserted-by":"publisher","first-page":"498","DOI":"10.3201\/eid1303.060294","volume":"13","author":"ET Tan","year":"2007","unstructured":"Tan ET, Robertson CA, Brynildsen S, Bresnitz E, Tan C, McDonald C (2007) Clostridium difficile-associated disease in New Jersey hospitals, 2000\u20132004. Emerg Infect Dis 13(3):498\u2013500. https:\/\/doi.org\/10.3201\/eid1303.060294","journal-title":"Emerg Infect Dis"},{"issue":"Suppl 2","key":"3348_CR21","doi-asserted-by":"publisher","first-page":"S66","DOI":"10.1093\/cid\/civ140","volume":"60","author":"CT Evans","year":"2015","unstructured":"Evans CT, Safdar N (2015) Current trends in the epidemiology and outcomes of Clostridium difficile infection. Clin Infect Dis 60(Suppl 2):S66\u2013S71. https:\/\/doi.org\/10.1093\/cid\/civ140","journal-title":"Clin Infect Dis"},{"issue":"1","key":"3348_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jhin.2012.02.004","volume":"81","author":"PN Wiegand","year":"2012","unstructured":"Wiegand PN, Nathwani D, Wilcox MH, Stephens J, Shelbaya A, Haider S (2012) Clinical and economic burden of Clostridium difficile infection in Europe: a systematic review of healthcare-facility-acquired infection. J Hosp Infect 81(1):1\u201314. https:\/\/doi.org\/10.1016\/j.jhin.2012.02.004","journal-title":"J Hosp Infect"},{"issue":"3","key":"3348_CR23","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.amjsurg.2007.11.017","volume":"196","author":"JF Hall","year":"2008","unstructured":"Hall JF, Berger D (2008) Outcome of colectomy for Clostridium difficile colitis: a plea for early surgical management. Am J Surg 196(3):384\u2013388. https:\/\/doi.org\/10.1016\/j.amjsurg.2007.11.017","journal-title":"Am J Surg"},{"issue":"5","key":"3348_CR24","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1086\/665318","volume":"33","author":"AM Kasper","year":"2012","unstructured":"Kasper AM, Nyazee HA, Yokoe DS, Mayer J, Mangino JE, Khan YM, Hota B, Fraser VJ, Dubberke ER, Centers for Disease C, Prevention Epicenters P (2012) A multicenter study of Clostridium difficile infection-related colectomy, 2000\u20132006. Infect Control Hosp Epidemiol 33(5):470\u2013476. https:\/\/doi.org\/10.1086\/665318","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"2","key":"3348_CR25","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1086\/511794","volume":"28","author":"F Barbut","year":"2007","unstructured":"Barbut F, Gariazzo B, Bonne L, Lalande V, Burghoffer B, Luiuz R, Petit JC (2007) Clinical features of Clostridium difficile-associated infections and molecular characterization of strains: results of a retrospective study, 2000\u20132004. Infect Control Hosp Epidemiol 28(2):131\u2013139. https:\/\/doi.org\/10.1086\/511794","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"12","key":"3348_CR26","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1007\/s10096-008-0564-9","volume":"27","author":"L Fenner","year":"2008","unstructured":"Fenner L, Frei R, Gregory M, Dangel M, Stranden A, Widmer AF (2008) Epidemiology of Clostridium difficile-associated disease at University Hospital Basel including molecular characterisation of the isolates 2006\u20132007. Eur J Clin Microbiol Infect Dis 27(12):1201\u20131207. https:\/\/doi.org\/10.1007\/s10096-008-0564-9","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"11","key":"3348_CR27","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1086\/430315","volume":"40","author":"J Pepin","year":"2005","unstructured":"Pepin J, Alary ME, Valiquette L, Raiche E, Ruel J, Fulop K, Godin D, Bourassa C (2005) Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada. Clin Infect Dis 40(11):1591\u20131597. https:\/\/doi.org\/10.1086\/430315","journal-title":"Clin Infect Dis"},{"issue":"1","key":"3348_CR28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.diagmicrobio.2016.09.023","volume":"87","author":"JH Sim","year":"2017","unstructured":"Sim JH, Truong C, Minot SS, Greenfield N, Budvytiene I, Lohith A, Anikst V, Pourmand N, Banaei N (2017) Determining the cause of recurrent Clostridium difficile infection using whole genome sequencing. Diagn Microbiol Infect Dis 87(1):11\u201316. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2016.09.023","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"5","key":"3348_CR29","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1503\/cmaj.1041104","volume":"171","author":"J Pepin","year":"2004","unstructured":"Pepin J, Valiquette L, Alary ME, Villemure P, Pelletier A, Forget K, Pepin K, Chouinard D (2004) Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ 171(5):466\u2013472. https:\/\/doi.org\/10.1503\/cmaj.1041104","journal-title":"CMAJ"},{"issue":"6","key":"3348_CR30","doi-asserted-by":"publisher","first-page":"929","DOI":"10.3201\/eid1406.071447","volume":"14","author":"MD Zilberberg","year":"2008","unstructured":"Zilberberg MD, Shorr AF, Kollef MH (2008) Increase in adult Clostridium difficile-related hospitalizations and case-fatality rate, United States, 2000\u20132005. Emerg Infect Dis 14(6):929\u2013931. https:\/\/doi.org\/10.3201\/eid1406.071447","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"3348_CR31","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.jinf.2009.08.019","volume":"59","author":"M Salazar","year":"2009","unstructured":"Salazar M, Baskin L, Garey KW, DuPont HL (2009) Clostridium difficile-related death rates in Texas 1999\u20132005. J Inf Secur 59(5):303\u2013307. https:\/\/doi.org\/10.1016\/j.jinf.2009.08.019","journal-title":"J Inf Secur"},{"issue":"4","key":"3348_CR32","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s10096-010-1127-4","volume":"30","author":"MP Hensgens","year":"2011","unstructured":"Hensgens MP, Goorhuis A, van Kinschot CM, Crobach MJ, Harmanus C, Kuijper EJ (2011) Clostridium difficile infection in an endemic setting in the Netherlands. Eur J Clin Microbiol Infect Dis 30(4):587\u2013593. https:\/\/doi.org\/10.1007\/s10096-010-1127-4","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"6","key":"3348_CR33","doi-asserted-by":"publisher","first-page":"e98400","DOI":"10.1371\/journal.pone.0098400","volume":"9","author":"CN Abou Chakra","year":"2014","unstructured":"Abou Chakra CN, Pepin J, Sirard S, Valiquette L (2014) Risk factors for recurrence, complications and mortality in Clostridium difficile infection: a systematic review. PLoS One 9(6):e98400. https:\/\/doi.org\/10.1371\/journal.pone.0098400","journal-title":"PLoS One"},{"key":"3348_CR34","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s12879-015-0895-y","volume":"15","author":"R Laza","year":"2015","unstructured":"Laza R, Jurac R, Crisan A, Lazureanu V, Licker M, Popovici ED, Baditoiu LM (2015) Clostridium difficile in western Romania: unfavourable outcome predictors in a hospital for infectious diseases. BMC Infect Dis 15:141. https:\/\/doi.org\/10.1186\/s12879-015-0895-y","journal-title":"BMC Infect Dis"},{"issue":"1","key":"3348_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jinf.2010.03.025","volume":"61","author":"JA Karas","year":"2010","unstructured":"Karas JA, Enoch DA, Aliyu SH (2010) A review of mortality due to Clostridium difficile infection. J Infect 61(1):1\u20138. https:\/\/doi.org\/10.1016\/j.jinf.2010.03.025","journal-title":"J Infect"},{"key":"3348_CR36","doi-asserted-by":"crossref","unstructured":"Davies KA, Ashwin H, Longshaw CM, Burns DA, Davis GL, Wilcox MH; EUCLID study group (2016) Diversity of Clostridium difficile PCR ribotypes in Europe: results from the European, multicentre, prospective, biannual, point-prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID), 2012 and 2013. Euro Surveill: 21 (29)","DOI":"10.2807\/1560-7917.ES.2016.21.29.30294"},{"issue":"8","key":"3348_CR37","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1093\/cid\/cis614","volume":"55","author":"MH Wilcox","year":"2012","unstructured":"Wilcox MH, Shetty N, Fawley WN, Shemko M, Coen P, Birtles A, Cairns M, Curran MD, Dodgson KJ, Green SM, Hardy KJ, Hawkey PM, Magee JG, Sails AD, Wren MW (2012) Changing epidemiology of Clostridium difficile infection following the introduction of a national ribotyping-based surveillance scheme in England. Clin Infect Dis 55(8):1056\u20131063. https:\/\/doi.org\/10.1093\/cid\/cis614","journal-title":"Clin Infect Dis"},{"key":"3348_CR38","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/S0140-6736(05)67420-X","volume":"9491","author":"M Warny","year":"2005","unstructured":"Warny M, Pepin J, Fang A, Killgore G, Thompson A, Brazier J, Frost E, McDonald LC (2005) Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 9491:1079\u20131084. https:\/\/doi.org\/10.1016\/S0140-6736(05)67420-X","journal-title":"Lancet"},{"issue":"12","key":"3348_CR39","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1093\/cid\/cis786","volume":"55","author":"ST Walk","year":"2012","unstructured":"Walk ST, Micic D, Jain R, Lo ES, Trivedi I, Liu EW, Almassalha LM, Ewing SA, Ring C, Galecki AT, Rogers MA, Washer L, Newton DW, Malani PN, Young VB, Aronoff DM (2012) Clostridium difficile ribotype does not predict severe infection. Clin Infect Dis 55(12):1661\u20131668. https:\/\/doi.org\/10.1093\/cid\/cis786","journal-title":"Clin Infect Dis"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-018-3348-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-018-3348-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-018-3348-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T22:13:21Z","timestamp":1604787201000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-018-3348-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,17]]},"references-count":39,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["3348"],"URL":"https:\/\/doi.org\/10.1007\/s10096-018-3348-x","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"type":"print","value":"0934-9723"},{"type":"electronic","value":"1435-4373"}],"subject":[],"published":{"date-parts":[[2018,8,17]]},"assertion":[{"value":"30 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Nagham Khanafer received a PhD grant from Sanofi Pasteur, non-financial support (travel expenses) from Alere, Astellas, and Sanofi Pasteur, and personal fees from Astellas; Fr\u00e9d\u00e9ric Barbut received personal fees and non-financial support (travel expenses) from Astellas Pharma Europe, Sanofi Pasteur, Pfizer, and Merck and scientific grants from Astellas Pharma Europe, bioM\u00e9rieux, bioSynex, Cepheid, Cubist, Diasorin, Quidel-Buhlmann, and R-bioPharm; Philippe Vanhems received scientific grants from Sanofi Pasteur, Sanofi MSD, and Anios and personal fees from Sanofi Pasteur, BioM\u00e9rieux, GSK, and Sanofi MSD; Christine Luxemburger and Clarisse Demont are employed by Sanofi Pasteur, France. The other authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}